• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

GLUCAGON-LIKE PEPTIDE 1

PPARgamma and drugs for Alzheimer’s and Diabetes

September 17, 2018Alzheimer's, Diabetes, Metabolic Disorders, Nervous System Disorders, Vizit Graphs
PPARgamma ad common drugs and two major diseases, Alzheimer’s and Diabetes

“Live graph” of PPARgamma associated with common drugs and two major diseases, Alzheimer’s and Diabetes. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

ACE IL6 CELL PROLIFERATION RHEUMATOID ARTHRITIS SARS-COV-2 METFORMIN INFLAMMATORY RESPONSE CD4 IMMUNE RESPONSE HELICOBACTER PYLORI LISTERIA MONOCYTOGENES CANCER TMPRSS2 COVID-19 AUTOPHAGY IFNG CELL DEATH ACE2 IL10 NFKB1 INSULIN CELL DIFFERENTIATION ANGIOTENSIN II AGING INFLAMMATION NEUTROPHILS STAPHYLOCOCCUS AUREUS COGNITION INTERFERON IMMUNITY COAGULATION IL1B PD-1 TNF APOPTOTIC PROCESS LACTATE DEHYDROGENASE ESCHERICHIA COLI CASP3 CHLOROQUINE PARKINSON DISEASE APOE RAS CANDIDA ALBICANS PSEUDOMONAS AERUGINOSA ALZHEIMER'S DISEASE

© 2020 Biovista Vizit All Rights Reserved.